Promising graphene-based nanomaterials and their biomedical applications and potential risks: A comprehensive review

J Li, H Zeng, Z Zeng, Y Zeng, T Xie - ACS biomaterials science & …, 2021 - ACS Publications
Graphene-based nanomaterials (GBNs) have been the subject of research focus in the
scientific community because of their excellent physical, chemical, electrical, mechanical …

Modulation of T cells by tryptophan metabolites in the kynurenine pathway

TW Stone, RO Williams - Trends in Pharmacological Sciences, 2023 - cell.com
Lymphocytes maturing in the thymus (T cells) are key factors in adaptive immunity and the
regulation of inflammation. The kynurenine pathway of tryptophan metabolism includes …

IDO and kynurenine metabolites in peripheral and CNS disorders

YS Huang, J Ogbechi, FI Clanchy, RO Williams… - Frontiers in …, 2020 - frontiersin.org
The importance of the kynurenine pathway in normal immune system function has led to an
appreciation of its possible contribution to autoimmune disorders such as rheumatoid …

Recent advances of quinones as a privileged structure in drug discovery

L Zhang, G Zhang, S Xu, Y Song - European Journal of Medicinal Chemistry, 2021 - Elsevier
Privileged structures are conductive to discover novel bioactive substances because they
can bind to multiple targets with high affinity. Quinones are considered to be a privileged …

Indoleamine and tryptophan 2, 3-dioxygenases as important future therapeutic targets

A Dolšak, S Gobec, M Sova - Pharmacology & Therapeutics, 2021 - Elsevier
Conversion of tryptophan to N-formylkynurenine is the first and rate-limiting step of the
tryptophan metabolic pathway (ie, the kynurenine pathway). This conversion is catalyzed by …

Interactions of IDO and the kynurenine pathway with cell transduction Systems and metabolism at the inflammation–cancer interface

TW Stone, RO Williams - Cancers, 2023 - mdpi.com
Simple Summary There is clear evidence that inflammation can contribute to the
development of cancers, but the underlying mechanisms are not fully understood. This …

Design, synthesis, spectroscopic characterization, single crystal X-ray analysis, in vitro α-amylase inhibition assay, DPPH free radical evaluation and computational …

M Devi, P Kumar, R Singh, J Sindhu… - European Journal of …, 2023 - Elsevier
In our quest to design and develop N/O-containing inhibitors of α-amylase, we have tried to
synergize the inhibitory action of 1, 4-naphthoquinone, imidazole and 1, 2, 3-triazole motifs …

Inhibition mechanisms of indoleamine 2, 3-dioxygenase 1 (IDO1)

UF Röhrig, A Reynaud, SR Majjigapu… - Journal of medicinal …, 2019 - ACS Publications
Indoleamine 2, 3-dioxygenase 1 (IDO1) catalyzes the rate-limiting step in the kynurenine
pathway of tryptophan metabolism, which is involved in immunity, neuronal function, and …

Development of indoleamine 2, 3-dioxygenase 1 inhibitors for cancer therapy and beyond: a recent perspective

X Feng, D Liao, D Liu, A Ping, Z Li… - Journal of Medicinal …, 2020 - ACS Publications
Indoleamine 2, 3-dioxygenase 1 (IDO1) has received increasing attention due to its
immunosuppressive function in connection with various diseases, including cancer. A recent …

Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy

J Yuan, Z Liu, Y Dong, F Gao, X Xia… - Journal of Medicinal …, 2023 - ACS Publications
Survivin is a novel attractive target for cancer therapy; however, it is considered undruggable
because it lacks enzymatic activities. Herein, we describe our efforts toward the discovery of …